Dragonfly Therapeutics' Project Finance Round

Dragonfly Therapeutics raised a round of funding on June 12, 2017. Investors include Celgene.

Dragonfly Therapeutics is a discovery-stage company developing drugs to stimulate immune responses against cancer. The company is developing novel first-in-class therapeutics targeted at natural kille…

Articles about Dragonfly Therapeutics' Project Finance Round: